J
James M. Tesoriero
Researcher at New York State Department of Health
Publications - 43
Citations - 3119
James M. Tesoriero is an academic researcher from New York State Department of Health. The author has contributed to research in topics: Acquired immunodeficiency syndrome (AIDS) & Population. The author has an hindex of 18, co-authored 36 publications receiving 2617 citations. Previous affiliations of James M. Tesoriero include State University of New York System.
Papers
More filters
Journal ArticleDOI
Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State.
Eli S. Rosenberg,Elizabeth Dufort,Tomoko Udo,Larissa A. Wilberschied,Jessica Kumar,James M. Tesoriero,Patti Weinberg,James N Kirkwood,Alison Muse,Jack DeHovitz,Debra Blog,Brad Hutton,David R. Holtgrave,Howard A. Zucker +13 more
TL;DR: Among patients hospitalized in metropolitan New York with COVID-19, treatment with hydroxychloroquine, azithromycin, or both, compared with neither treatment, was not significantly associated with differences in in-hospital mortality.
Journal ArticleDOI
Abbreviated regimens of zidovudine prophylaxis and perinatal transmission of the human immunodeficiency virus.
Nancy Wade,Guthrie S. Birkhead,Barbara L. Warren,T. T. Charbonneau,P. T. French,Ling Wang,J. B. Baum,James M. Tesoriero,R. Savicki +8 more
TL;DR: These results confirm the efficacy of zidovudine prophylaxis and suggest that there are reductions in the rates of perinatal transmission of HIV even with the use of abbreviated regimens that are begun intra partum or in the first 48 hours of life.
Journal ArticleDOI
Smoking among HIV positive New Yorkers: prevalence, frequency, and opportunities for cessation.
TL;DR: HIV/AIDS service providers are inadequately addressing the high smoking rate among PLWHA, despite being uniquely suited to do so, and efforts are needed to educate providers about the need for, and interest in, tobacco cessation.
Journal ArticleDOI
Cumulative incidence and diagnosis of SARS-CoV-2 infection in New York.
Eli S. Rosenberg,James M. Tesoriero,Elizabeth M. Rosenthal,Rakkoo Chung,Meredith A. Barranco,Linda M. Styer,Monica M. Parker,Shu Yin John Leung,Johanne E. Morne,Danielle Greene,David R. Holtgrave,Dina Hoefer,Jessica Kumar,Tomoko Udo,Brad Hutton,Howard A. Zucker +15 more
TL;DR: From the largest US serosurvey to date, it is estimated > 2 million adult New York residents were infected through late March, with substantial disparities, although cumulative incidence remained below herd immunity thresholds.
Journal ArticleDOI
COVID-19 Outcomes Among Persons Living With or Without Diagnosed HIV Infection in New York State.
James M. Tesoriero,James M. Tesoriero,Carol-Ann Swain,Jennifer L. Pierce,Lucila Zamboni,Meng Wu,David R. Holtgrave,Charles J. Gonzalez,Tomoko Udo,Johanne E. Morne,Johanne E. Morne,Rachel Hart-Malloy,Rachel Hart-Malloy,Deepa T Rajulu,Shu-Yin John Leung,Eli S. Rosenberg +15 more
TL;DR: In a cohort study of linked statewide HIV diagnosis, COVID-19 laboratory diagnosis, and hospitalization databases, persons living with an HIV diagnosis were more likely to receive a diagnosis of, be hospitalized with, and die in-hospital with CO VID-19 compared with those not living with a HIV diagnosis.